 |
Corporate News
21-Mar-25
|
|
|
|
|
|
|
|
|
|
|
|
Lupin allots 24,101 equity shares under ESOP
|
|
|
|
|
|
|
|
Lupin has allotted 24,101 equity shares under ESOP on 21 March 2025. In view of the above, the issued and paid-up share capital of the Company has increased to Rs 91,31,30,090 consisting of 45,65,65,045 equity shares of Rs 2/- each.
|
|
|
|
Previous News |
Lupin rallies after receiving USFDA nod for Tolvaptan tablets
(
Hot Pursuit
-
24-Apr-25
11:40
)
|
|
|
Lupin receives USFDA approval for Tolvaptan Tablets
(
Corporate News
-
24-Apr-25
11:06
)
|
|
|
Lupin gets EIR from USFDA for Nagpur facility
(
Hot Pursuit
-
17-Apr-25
15:00
)
|
|
|
Nanomi wins prestigious CMO Award for Life Science Leadership in Drug Delivery
(
Corporate News
-
21-Mar-25
19:12
)
|
|
|
Lupin allots 24,101 equity shares under ESOP
(
Corporate News
-
21-Mar-25
16:10
)
|
|
|
Lupin receives USFDA tentative approval for Amifampridine Tablets
(
Corporate News
-
17-Mar-25
13:36
)
|
|
|
Lupin gains after getting tentative USFDA approval for Amifampridine tablets 10 mg
(
Hot Pursuit
-
17-Mar-25
10:44
)
|
|
|
Lupin launches Rivaroxaban drug in US
(
Hot Pursuit
-
10-Mar-25
10:02
)
|
|
|
Lupin launches Rivaroxaban Tablets USP, 2.5 mg in the US
(
Corporate News
-
07-Mar-25
16:43
)
|
|
|
Lupin Ltd spurts 0.59%, up for five straight sessions
(
Hot Pursuit
-
06-Mar-25
13:00
)
|
|
|
Lupin allots 59,940 equity shares under ESOP
(
Corporate News
-
27-Feb-25
12:40
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|